CAR research at MDAnderson ... Patient Power I... - CLL Support

CLL Support

23,253 members39,949 posts

CAR research at MDAnderson ... Patient Power Interview from ASH 2012

Cllcanada profile image
CllcanadaTop Poster CURE Hero
3 Replies

Dr. William Wierda is head of the CLL section there and is leading some innovative research with CARs that could lead to making it less expensive and more accessible for more patients. He explains this leading-edge research in this interview recorded at the 2012 meeting of the American Society of Hematology.

patientpower.info/video/new...

~chris

CLL CANADA cllcanada.ca

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
3 Replies
HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin

Chris, Thanks for forwarding this I think many were waiting for it to hit their mailbox. Good news for Christmas.

The topic is very complicated but this interview i found joined a lot of the dots. I think I understand how the treatment is made CLL specific by designing it to go after ROR1 a protein specific to the tumor cell.

More importantly the long term strategy "that could lead to making it less expensive and more accessible for more patients", Was what I had been waiting to hear. Yes it's on the drawing board and it's a long way away if they can make it happen. But I understand why the experts are so optimistic now.

How long until results from the fist ROR1 CART trials will be available? My thoughts and gratitude are with these brave pioneers and those that are in the early CD19 CART

Nick

jangreen profile image
jangreen

Hi This sounds like the thing we have been waiting for. I know its still some way off but its a start. Its hopeful for people like me who hope to stay in remission long enough to enjoy the results of this work. It was also very helpful to have gone to the CLL meeting at GSMK in Sept where some of this protein research was explained. Its good news.

Cllcanada profile image
CllcanadaTop Poster CURE Hero

Here is th most recent paper from ASH 2012 on the UPENN pilot trial...

ash.confex.com/ash/2012/web...

Not what you're looking for?

You may also like...

Jeff Sharman - ASH 2016 with Patient Power

'Just back from ASH 2016. Plenty of interesting things to discuss. I did a sit down visit...
AussieNeil profile image
Partner

Patient Power interviews Dr Michael Keating at ASH 2012. FCR and the transition to better, kinder treatments.

In this 6 minute interview by Andrew Schorr, Dr Michael Keating of MD Anderson, the father of FCR,...
AussieNeil profile image
Partner

Part 2 of ASH Interview with Dr. Sharman, a patient meeting in Seattle and off to iwCLL later tonight

Friends, This week on the CLL Society website, in our Conference coverage section, we share the...
bkoffman profile image
CLL CURE Hero

ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"

Dr Sharman's blog http://www.cll-nhl.com, is well worth keeping an eye on for pertinent but easily...
AussieNeil profile image
Partner

ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of venetoclax for CLL

Today we posted on ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of...
bkoffman profile image
CLL CURE Hero

Moderation team

See all
Newdawn profile image
NewdawnAdministrator
Jm954 profile image
Jm954Administrator
AussieNeil profile image
AussieNeilAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.